Skip to main content

Gates Foundation Awards Md. Vaccine Center $5.6M for Pathogen Dx; Illumina, Ibis Tapped as Subcontractors

NEW YORK (GenomeWeb News) The Center for Vaccine Development at the University of Maryland’s School of Medicine said today that it has been awarded a $5.6 million grant from the Bill and Melinda Gates Foundation to develop a diagnostic for diarrheal disease.
Illumina and Ibis Biosciences will serve as subcontractors on the grant and will provide genomics and pathogenic identification services, the university said.
The center plans to develop a diagnostic that will be faster and more accurate than available models and will be aimed at identifying pathogens that cause diarrheal problems in developing countries.
This center will “detect all of the important organisms involved in diarrheal diseases in developing countries,” the CVD said in a statement.
The research will be conducted on fecal samples obtained from Bangladesh, Mali, and Kenya through an agreement with researchers from the Center for Vaccine Development.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.